Ausgabe 6/2022
Inhalt (15 Artikel)
Narrative Review of the Emerging Therapeutic Role of Brodalumab in Difficult-to-Treat Psoriasis
Alan Menter, Tina Bhutani, Benjamin Ehst, Boni Elewski, Abby Jacobson
Real-Life Effectiveness of Adalimumab Biosimilars in Patients with Chronic Plaque Psoriasis
Francesco Bellinato, Paolo Gisondi, Elena Mason, Paolo Ricci, Martina Maurelli, Giampiero Girolomoni
Minimally Invasive Skin Transcriptome Extraction Using a Dermal Biomarker Patch
Sherrif F. Ibrahim, Bradford J. Taft, Yipeng Wang, Byung-In Lee, Eric Andrade, Christian Abaya, Shreya Pramanick, Thejus Mannath, Katherine A. Hurley, Tahir A. Mahmood, Tobin J. Dickerson
Efficacy and Safety of Using Noninsulated Microneedle Radiofrequency Alone Versus in Combination with Polynucleotides for the Treatment of Melasma: A Pilot Study
Ma. Christina B. Gulfan, Rungsima Wanitphakdeedecha, Supisara Wongdama, Nuttagarn Jantanapornchai, Chadakan Yan, Sarawalai Rakchart
Real-World Effectiveness of Dupilumab in Atopic Dermatitis Patients: Analysis of an Electronic Medical Records Dataset
Lawrence F. Eichenfield, April Armstrong, Emma Guttman-Yassky, Peter A. Lio, Chi-Chang Chen, Dionne M. Hines, Catherine B. McGuiness, Sohini Ganguli, Dimittri Delevry, Debra Sierka, Usha G. Mallya
Utilization Trends and Impact of Secukinumab Treatment on Clinical Outcomes in Biologic-Naive Patients with Psoriasis in a US Real-World Setting
Bruce Strober, Dhaval Patil, Robert R. McLean, Melissa Moore-Clingenpeel, Ning Guo, Eugenia Levi, Mark Lebwohl
Symptom Experience and Content Validity of the Psoriasis Symptom Scale (PSS) in Patients with Generalized Pustular Psoriasis (GPP)
A. David Burden, Ulrich Mrowietz, Anne M. Skalicky, Anne M. Rentz, Dirk Esser, Tristan Gloede, Christian Thoma, Alan Menter
Desire for Alternative Treatment Options in Patients with Atopic Dermatitis in Japan: Results of a Web-Based Cross-Sectional Study (AD-JOIN Study)
Takeshi Nakahara, Shunya Takemoto, Hiroyuki Houzawa, Masahiko Nakayama
Efficacy and Safety of Certolizumab Pegol in Japanese Patients with Generalized Pustular Psoriasis and Erythrodermic Psoriasis: 52-Week Results
Yukari Okubo, Yoshinori Umezawa, Shinya Sakurai, Naoki Hoshii, Hidemi Nakagawa
Baseline Demographics and Severity and Burden of Atopic Dermatitis in Adult Patients Initiating Dupilumab Treatment in a Real-World Registry (PROSE)
Jerry Bagel, Tien Q. Nguyen, Hermenio Lima, Neal Jain, David M. Pariser, Sylvia Hsu, Gil Yosipovitch, Haixin Zhang, Jingdong Chao, Shikha Bansal, Zhen Chen, Daniel Richman, Andrew Korotzer, Marius Ardeleanu
Safety of Ixekizumab in Adult Patients with Moderate-to-Severe Psoriasis: Data from 17 Clinical Trials with Over 18,000 Patient-Years of Exposure
Christopher E. M. Griffiths, Melinda Gooderham, Jean-Frederic Colombel, Tadashi Terui, Ana P. Accioly, Gaia Gallo, Danting Zhu, Andrew Blauvelt
Cost-Effectiveness Analysis Update of the Adjuvanted Recombinant Zoster Vaccine in Japanese Older Adults
Lida Teng, Akiko Mizukami, Cheryl Ng, Nikolaos Giannelos, Desmond Curran, Tomohide Sato, Christa Lee, Taizo Matsuki
Efficacy and Safety of Apremilast in the Treatment of Patients with Mild-to-Moderate Psoriasis in Japan: Results from PROMINENT, A Phase 3b, Open-Label, Single-Arm Study
Yukari Okubo, Hidetoshi Takahashi, Ryosuke Hino, Koki Endo, Satoru Kikuchi, Yasushi Ozeki, Taichi Nakamura, Maria Paris, Masatoshi Abe
Indirect Treatment Comparison of Baricitinib versus Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis
Marjolein S. de Bruin-Weller, Esther Serra-Baldrich, Sebastien Barbarot, Susanne Grond, Christopher Schuster, Helmut Petto, Jean-Philippe Capron, Afaf Raibouaa, Thomas Werfel
The Tuberculosis Positive Conversion Rate Among Psoriasis Patients Treated with Adalimumab and Secukinumab: A Single-Center Retrospective Study in China
Yue Xiao, Hui Chen, Qin Zou, Yiyi Wang, Yuanxia Gu, Jinqiu Wang, Wei Yan, Wei Li